Gregory Page - Corteva Independent Chairman of the Board
| CTVA Stock | USD 57.41 0.25 0.43% |
Insider
Gregory Page is Independent Chairman of the Board of Corteva since 2019.
| Age | 69 |
| Tenure | 5 years |
| Address | 9330 Zionsville Road, Indianapolis, IN, United States, 46268 |
| Phone | 833 267 8382 |
| Web | https://www.corteva.com |
Corteva Management Efficiency
The company has return on total asset (ROA) of 0.0261 % which means that it generated a profit of $0.0261 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.027 %, meaning that it created $0.027 on every $100 dollars invested by stockholders. Corteva's management efficiency ratios could be used to measure how well Corteva manages its routine affairs as well as how well it operates its assets and liabilities. At present, Corteva's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.02, whereas Return On Capital Employed is forecasted to decline to 0.03. At present, Corteva's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 36.2 B.Similar Executives
| Showing other executives | INSIDER Age | ||
| David Kotch | FMC Corporation | N/A | |
| Michael McGrane | CF Industries Holdings | 50 | |
| Kemdirk Kempthorne | FMC Corporation | 69 | |
| M Zirakparvar | American Vanguard | 70 | |
| Abizar Zaki | FMC Corporation | N/A | |
| Marisol Angelini | American Vanguard | N/A | |
| Gadi Lesin | ICL Israel Chemicals | 53 | |
| Chris Millington | ICL Israel Chemicals | 52 | |
| Eli Amon | ICL Israel Chemicals | 54 | |
| Megan Fielding | Nutrien | N/A | |
| Kyle Smith | Intrepid Potash | 47 | |
| Mark Thompson | Nutrien | N/A | |
| Linda Dempsey | CF Industries Holdings | 60 | |
| Jason Newton | Nutrien | N/A | |
| Karen Totland | FMC Corporation | N/A | |
| Timothy Esq | American Vanguard | 64 | |
| Deborah DeHaas | CF Industries Holdings | 61 | |
| Meir Mergi | ICL Israel Chemicals | 58 | |
| Amir Meshulam | ICL Israel Chemicals | 44 | |
| Aya Landman | ICL Israel Chemicals | N/A | |
| Lilach GevaHarel | ICL Israel Chemicals | 44 | |
Management Performance
| Return On Equity | 0.027 | ||||
| Return On Asset | 0.0261 |
Corteva Leadership Team
Elected by the shareholders, the Corteva's board of directors comprises two types of representatives: Corteva inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Corteva. The board's role is to monitor Corteva's management team and ensure that shareholders' interests are well served. Corteva's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Corteva's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, Executive Officer | ||
| Brian Titus, Principal Accounting Officer, Vice President Controller | ||
| Marcos Lutz, Independent Director | ||
| David Anderson, Chief Financial Officer, Executive Vice President | ||
| Patrick Ward, Independent Director | ||
| Cornel Fuerer, Senior Vice President General Counsel, Secretary | ||
| Sid Gorham, CEO Platform | ||
| Charles Magro, President, Chief Executive Officer, Director | ||
| Rebecca Liebert, Independent Director | ||
| Brook Cunningham, Senior Officer | ||
| Lois Juliber, Independent Director | ||
| Jeffrey Rudolph, Executive Relations | ||
| Kerry Preete, Independent Director | ||
| David Johnson, Executive CFO | ||
| Timothy Glenn, Executive Vice President Chief Commercial Officer | ||
| James Collins, Chief Executive Officer, Director | ||
| Gregory Friedman, Chief Financial Officer, Executive Vice President | ||
| Sam Eathington, Senior Vice President, Chief Technology Officer | ||
| Kimberly Booth, Vice Relations | ||
| Robert Brown, Independent Director | ||
| Lamberto Andreotti, Independent Director | ||
| Nayaki Nayyar, Independent Director | ||
| Lee Thomas, Independent Director | ||
| David Everitt, Independent Director | ||
| Gregory Page, Independent Chairman of the Board | ||
| Michael Johanns, Independent Director | ||
| MBA B, CEO Director | ||
| Robert King, Executive Vice President - Crop Protection Business Unit | ||
| Samuel Eathington, Executive Officer | ||
| Karen Grimes, Independent Director | ||
| Klaus Engel, Independent Director | ||
| Audrey Grimm, Chief VP | ||
| Janet Giesselman, Independent Director | ||
| Meghan Cassidy, Chief Human Resource Officer, Senior Vice President | ||
| BS MBA, Ex CFO | ||
| Rajan Gajaria, Executive Vice President - Business Platforms |
Corteva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Corteva a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.027 | ||||
| Return On Asset | 0.0261 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 42.85 B | ||||
| Shares Outstanding | 687.29 M | ||||
| Shares Owned By Insiders | 0.08 % | ||||
| Shares Owned By Institutions | 85.90 % | ||||
| Number Of Shares Shorted | 8.03 M | ||||
| Price To Earning | 29.88 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Corteva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Corteva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Corteva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Corteva Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corteva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Corteva Stock refer to our How to Trade Corteva Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corteva. If investors know Corteva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corteva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.508 | Dividend Share 0.66 | Earnings Share 0.96 | Revenue Per Share 23.841 | Quarterly Revenue Growth (0.10) |
The market value of Corteva is measured differently than its book value, which is the value of Corteva that is recorded on the company's balance sheet. Investors also form their own opinion of Corteva's value that differs from its market value or its book value, called intrinsic value, which is Corteva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corteva's market value can be influenced by many factors that don't directly affect Corteva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corteva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Corteva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corteva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.